These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23095652)

  • 1. [Polyneuropathy associated with monoclonal gammopathy of undetermined significance].
    Moth Henriksen M; Kolmos EB; Abildgaard N; Schrøder HD; Sindrup S
    Ugeskr Laeger; 2012 Oct; 174(43):2630-4. PubMed ID: 23095652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
    Kuijf ML; Eurelings M; Tio-Gillen AP; van Doorn PA; van den Berg LH; Hooijkaas H; Stork J; Notermans NC; Jacobs BC
    Neurology; 2009 Sep; 73(9):688-95. PubMed ID: 19720975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of severe chronic inflammatory demyelinating polyradiculoneuropathy with monoclonal gammopathy of undetermined significance with alternating immunoglobulin class to IgM from IgA].
    Hayashi S; Nagamine S; Makioka K; Kusunoki S; Okamoto K
    Rinsho Shinkeigaku; 2016 Sep; 56(9):593-9. PubMed ID: 27580763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
    Steiner N; Schwärzler A; Göbel G; Löscher W; Wanschitz J; Gunsilius E
    Oncotarget; 2017 Jan; 8(3):5081-5091. PubMed ID: 27974705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurological manifestations of monoclonal gammopathies].
    Chassande B; Léger JM
    Rev Prat; 1993 Feb; 43(3):314-6. PubMed ID: 8389055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful management of polyneuropathy associated with IgM gammopathy of undetermined significance with antibody-based immunoadsorption.
    Toepfer M; Schroeder M; Müller-Felber W; Lochmüller H; Sitter T; Pongratz D; Schiffl H
    Clin Nephrol; 2000 May; 53(5):404-7. PubMed ID: 11305816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widening of myelin lamellae in polyneuropathy with immunoglobulin-M monoclonal gammopathy, without activity against myelin-associated glycoprotein, responsive to treatment.
    Vallat JM; Deschamps N; Richard L; Magy L; Devaux J; Mathis S
    Neuromuscul Disord; 2022 Aug; 32(8):678-681. PubMed ID: 35618575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of sensory ataxic axonal polyneuropathy with IgGλ monoclonal gammopathy successfully treated with intravenous immunoglobulin therapy].
    Kanatsuka Y; Hasegawa O; Imazeki R; Yamamoto M
    Rinsho Shinkeigaku; 2015; 55(5):349-52. PubMed ID: 26028199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathy associated with monoclonal gammopathies of undetermined significance.
    Gosselin S; Kyle RA; Dyck PJ
    Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment with rituximab in two cases of IgM-monoclonal gammopathy of undetermined significance (MGUS) neuropathy].
    Koike M; Sugimoto K; Tusui M; Yahata Y
    Rinsho Ketsueki; 2012 Apr; 53(4):450-4. PubMed ID: 22687979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyneuropathy and monoclonal gammopathy of undetermined significance (MGUS); update of a clinical experience.
    Matà S; Torricelli S; Barilaro A; Grippo A; Forleo P; Del Mastio M; Sorbi S
    J Neurol Sci; 2021 Apr; 423():117335. PubMed ID: 33647732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgM monoclonal gammopathy-associated neuropathies with different IgM specificity.
    Matà S; Borsini W; Ambrosini S; Toscani L; Barilaro A; Piacentini S; Sorbi S; Lolli F
    Eur J Neurol; 2011 Aug; 18(8):1067-73. PubMed ID: 21261794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features, evaluation, and treatment of patients with polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS).
    Gorson KC
    J Clin Apher; 1999; 14(3):149-53. PubMed ID: 10540371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM monoclonal gammopathy and neuropathy in two siblings.
    Jensen TS; Schrøder HD; Jønsson V; Ernerudh J; Stigsby B; Kamieniecka Z; Hippe E; Trojaborg W
    J Neurol Neurosurg Psychiatry; 1988 Oct; 51(10):1308-15. PubMed ID: 2852210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological progression of myelin abnormalities in IgM-monoclonal gammopathy of undetermined significance anti-myelin-associated glycoprotein neuropathy.
    Kawagashira Y; Koike H; Tomita M; Morozumi S; Iijima M; Nakamura T; Katsuno M; Tanaka F; Sobue G
    J Neuropathol Exp Neurol; 2010 Nov; 69(11):1143-57. PubMed ID: 20940626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size.
    Fisher MA; Wilson JR
    Neurol Clin Neurophysiol; 2002; 2002(3):2-7. PubMed ID: 12028821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of MGUS in DSP.
    Abraham A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    Muscle Nerve; 2018 Jun; 57(6):1018-1021. PubMed ID: 29314079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study.
    Niermeijer JM; Fischer K; Eurelings M; Franssen H; Wokke JH; Notermans NC
    Neurology; 2010 Feb; 74(5):406-12. PubMed ID: 20124206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyneuropathy associated with IgG/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases.
    Magy L; Chassande B; Maisonobe T; Bouche P; Vallat JM; Léger JM
    Eur J Neurol; 2003 Nov; 10(6):677-85. PubMed ID: 14641513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninfectious mixed cryoglobulinaemic glomerulonephritis and monoclonal gammopathy of undetermined significance: a coincidental association?
    Flavell AL; Fullinfaw RO; Smith ER; Holt SG; Finlay MJ; Barbour TD
    BMC Nephrol; 2020 Jul; 21(1):293. PubMed ID: 32703171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.